HEADER CARBOHYDRATE BINDING PROTEIN 23-SEP-10 3OY8 TITLE CRYSTAL STRUCTURE OF HUMAN GALECTIN-1 IN COMPLEX WITH LACTOBIONIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GAL-1, LECTIN GALACTOSIDE-BINDING SOLUBLE 1, BETA- COMPND 5 GALACTOSIDE-BINDING LECTIN L-14-I, LACTOSE-BINDING LECTIN 1, S-LAC COMPND 6 LECTIN 1, GALAPTIN, 14 KDA LECTIN, HPL, HBL, PUTATIVE MAPK-ACTIVATING COMPND 7 PROTEIN PM12, 14 KDA LAMININ-BINDING PROTEIN, HLBP14; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: GALECTIN-1; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: GAL-1, LECTIN GALACTOSIDE-BINDING SOLUBLE 1, BETA- COMPND 13 GALACTOSIDE-BINDING LECTIN L-14-I, LACTOSE-BINDING LECTIN 1, S-LAC COMPND 14 LECTIN 1, GALAPTIN, 14 KDA LECTIN, HPL, HBL, PUTATIVE MAPK-ACTIVATING COMPND 15 PROTEIN PM12, 14 KDA LAMININ-BINDING PROTEIN, HLBP14; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: LGALS1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CARBOHYDRATE BINDING PROTEIN, GALECTIN, LACTOBIONIC ACID EXPDTA X-RAY DIFFRACTION AUTHOR H.BLANCHARD,P.M.COLLINS REVDAT 4 20-NOV-24 3OY8 1 HETSYN REVDAT 3 29-JUL-20 3OY8 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 08-NOV-17 3OY8 1 REMARK REVDAT 1 03-NOV-10 3OY8 0 JRNL AUTH K.A.STANNARD,P.M.COLLINS,K.ITO,E.M.SULLIVAN,S.A.SCOTT, JRNL AUTH 2 E.GABUTERO,I.DARREN GRICE,P.LOW,U.J.NILSSON,H.LEFFLER, JRNL AUTH 3 H.BLANCHARD,S.J.RALPH JRNL TITL GALECTIN INHIBITORY DISACCHARIDES PROMOTE TUMOUR IMMUNITY IN JRNL TITL 2 A BREAST CANCER MODEL JRNL REF CANCER LETT. 2010 JRNL REFN ESSN 1872-7980 JRNL PMID 20826047 JRNL DOI 10.1016/J.CANLET.2010.08.005 REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 14103 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 752 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 748 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 69.01 REMARK 3 BIN R VALUE (WORKING SET) : 0.2090 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2065 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 139 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.56000 REMARK 3 B22 (A**2) : -1.42000 REMARK 3 B33 (A**2) : -0.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.264 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.162 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2185 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2959 ; 1.051 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 280 ;13.492 ; 5.214 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 105 ;33.288 ;25.238 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 331 ;13.439 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;16.390 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 328 ; 0.066 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1682 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 705 ; 0.181 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1438 ; 0.304 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 119 ; 0.115 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 28 ; 0.134 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 6 ; 0.223 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1347 ; 3.450 ; 4.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2156 ; 5.238 ; 6.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 838 ; 1.770 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 800 ; 2.658 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES: REFINED INDIVIDUALLY REMARK 4 REMARK 4 3OY8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000061721. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : MACSCIENCE REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER SMART 6000 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14888 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 56.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: FOURIER SYNTHESIS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4-8 MICROLITRE DROPS CONSISTING OF REMARK 280 EQUAL VOLUMES OF PROTEIN SOLUTION (20 MM SODIUM POTASSIUM REMARK 280 PHOSPHATE BUFFER, PH 7.0, AND PROTEIN AT CONCENTRATION OF 10 MG/ REMARK 280 ML) AND RESERVOIR SOLUTION (0.2 M AMMONIUM SULPHATE, 25% W/V REMARK 280 POLYETHYLENE GLYCOL 4000, 0.1M SODIUM ACETATE TRIHYDRATE, PH 6.2) REMARK 280 , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.35550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.81100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.28500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.81100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.35550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.28500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 86.65 -154.38 REMARK 500 PRO A 78 34.53 -92.53 REMARK 500 ASN A 113 52.39 -107.85 REMARK 500 SER B 29 143.11 -176.68 REMARK 500 PHE B 77 82.61 -150.89 REMARK 500 PRO B 78 33.68 -92.21 REMARK 500 ASP B 125 57.30 -92.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OYW RELATED DB: PDB DBREF 3OY8 A 1 134 UNP P09382 LEG1_HUMAN 2 135 DBREF 3OY8 B 1 134 UNP P09382 LEG1_HUMAN 2 135 SEQRES 1 A 134 ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO SEQRES 2 A 134 GLY GLU CSO LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP SEQRES 3 A 134 ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN SEQRES 4 A 134 ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS SEQRES 5 A 134 GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY SEQRES 6 A 134 GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO SEQRES 7 A 134 PHE GLN PRO GLY SER VAL ALA GLU VAL CSO ILE THR PHE SEQRES 8 A 134 ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR SEQRES 9 A 134 GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE SEQRES 10 A 134 ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME SEQRES 11 A 134 VAL ALA PHE ASP SEQRES 1 B 134 ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU LYS PRO SEQRES 2 B 134 GLY GLU CSO LEU ARG VAL ARG GLY GLU VAL ALA PRO ASP SEQRES 3 B 134 ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SER ASN SEQRES 4 B 134 ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN ALA HIS SEQRES 5 B 134 GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS ASP GLY SEQRES 6 B 134 GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL PHE PRO SEQRES 7 B 134 PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE THR PHE SEQRES 8 B 134 ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP GLY TYR SEQRES 9 B 134 GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU ALA ILE SEQRES 10 B 134 ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE LYS CME SEQRES 11 B 134 VAL ALA PHE ASP MODRES 3OY8 CSO A 16 CYS S-HYDROXYCYSTEINE MODRES 3OY8 CSO A 88 CYS S-HYDROXYCYSTEINE MODRES 3OY8 CME A 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3OY8 CSO B 16 CYS S-HYDROXYCYSTEINE MODRES 3OY8 CME B 88 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 3OY8 CME B 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CSO A 16 7 HET CSO A 88 7 HET CME A 130 10 HET CSO B 16 7 HET CME B 88 10 HET CME B 130 10 HET GCO C 1 13 HET GAL C 2 11 HET GCO D 1 13 HET GAL D 2 11 HETNAM CSO S-HYDROXYCYSTEINE HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM GCO D-GLUCONIC ACID HETNAM GAL BETA-D-GALACTOPYRANOSE HETSYN GCO GLUCONIC ACID HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE FORMUL 1 CSO 3(C3 H7 N O3 S) FORMUL 1 CME 3(C5 H11 N O3 S2) FORMUL 3 GCO 2(C6 H12 O7) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 5 HOH *139(H2 O) HELIX 1 1 PRO A 101 GLY A 103 5 3 HELIX 2 2 PRO B 101 GLY B 103 5 3 SHEET 1 A12 ALA A 67 TRP A 68 0 SHEET 2 A12 ASP A 54 ASP A 64 -1 N ASP A 64 O ALA A 67 SHEET 3 A12 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 A12 PHE A 30 ASP A 37 -1 N LYS A 36 O ASN A 40 SHEET 5 A12 ILE A 117 GLY A 124 -1 O ALA A 121 N ASN A 33 SHEET 6 A12 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 A12 VAL B 5 LEU B 11 -1 O VAL B 5 N SER A 7 SHEET 8 A12 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 A12 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 A12 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 A12 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 A12 ALA B 67 TRP B 68 -1 O ALA B 67 N ASP B 64 SHEET 1 B12 GLN A 72 ARG A 73 0 SHEET 2 B12 ASP A 54 ASP A 64 -1 N CYS A 60 O GLN A 72 SHEET 3 B12 ASN A 40 ALA A 51 -1 N ARG A 48 O THR A 57 SHEET 4 B12 PHE A 30 ASP A 37 -1 N LYS A 36 O ASN A 40 SHEET 5 B12 ILE A 117 GLY A 124 -1 O ALA A 121 N ASN A 33 SHEET 6 B12 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 B12 VAL B 5 LEU B 11 -1 O VAL B 5 N SER A 7 SHEET 8 B12 ILE B 117 GLY B 124 -1 O MET B 120 N ALA B 6 SHEET 9 B12 PHE B 30 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 B12 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 B12 ASP B 54 ASP B 64 -1 O THR B 57 N ARG B 48 SHEET 12 B12 GLN B 72 ARG B 73 -1 O GLN B 72 N CYS B 60 SHEET 1 C10 GLU A 105 PRO A 109 0 SHEET 2 C10 ASN A 95 LYS A 99 -1 N LEU A 96 O PHE A 108 SHEET 3 C10 VAL A 84 PHE A 91 -1 N CSO A 88 O LYS A 99 SHEET 4 C10 CSO A 16 VAL A 23 -1 N VAL A 19 O VAL A 87 SHEET 5 C10 PHE A 126 ASP A 134 -1 O ASP A 134 N CSO A 16 SHEET 6 C10 PHE B 126 ASP B 134 -1 O VAL B 131 N VAL A 131 SHEET 7 C10 CSO B 16 VAL B 23 -1 N ARG B 20 O LYS B 129 SHEET 8 C10 VAL B 84 PHE B 91 -1 O ILE B 89 N LEU B 17 SHEET 9 C10 ASN B 95 LYS B 99 -1 O LYS B 99 N CME B 88 SHEET 10 C10 GLU B 105 PRO B 109 -1 O PHE B 108 N LEU B 96 LINK C GLU A 15 N CSO A 16 1555 1555 1.33 LINK C CSO A 16 N LEU A 17 1555 1555 1.33 LINK C VAL A 87 N CSO A 88 1555 1555 1.34 LINK C CSO A 88 N ILE A 89 1555 1555 1.33 LINK C LYS A 129 N CME A 130 1555 1555 1.33 LINK C CME A 130 N VAL A 131 1555 1555 1.33 LINK C GLU B 15 N CSO B 16 1555 1555 1.33 LINK C CSO B 16 N LEU B 17 1555 1555 1.33 LINK C VAL B 87 N CME B 88 1555 1555 1.33 LINK C CME B 88 N ILE B 89 1555 1555 1.33 LINK C LYS B 129 N CME B 130 1555 1555 1.33 LINK C CME B 130 N VAL B 131 1555 1555 1.33 LINK O4 GCO C 1 C1 GAL C 2 1555 1555 1.33 LINK O4 GCO D 1 C1 GAL D 2 1555 1555 1.34 CRYST1 44.711 58.570 111.622 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022366 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017074 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008959 0.00000